Paper Details

  1. Home
  2. Paper Details

Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.

Author: BoluytNicole, KramerSharon, RottierBart L, ScholtenRob J P M

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Inhaled corticosteroids (ICS) are the most common treatment for asthma in children. However, there are concerns about potential side effects, such as slowed growth. Ciclesonide is a new type of ICS that may have fewer side effects and can be taken once a day, which may improve adherence.
Paper Details　
Original Abstract of the Article :
Inhaled corticosteroids (ICS) are the cornerstone of asthma maintenance treatment in children. Particularly among parents, there is concern about the safety of ICS as studies in children have shown reduced growth. Small-particle-size ICS targeting the smaller airways have improved lung deposition an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD010352

データ提供：米国国立医学図書館（NLM）

Ciclesonide: A Promising Inhaled Corticosteroid for Childhood Asthma

Asthma, a chronic respiratory condition affecting millions of children, requires careful management to control symptoms and minimize the impact on daily life. Inhaled corticosteroids (ICSs) are a cornerstone of asthma treatment, but concerns about potential side effects, particularly reduced growth, persist. This study examines the potential of ciclesonide, a relatively new ICS, as a safe and effective option for treating chronic asthma in children. The authors highlight the advantages of ciclesonide, including its small particle size, targeted delivery to the airways, and once-daily dosing, which may improve adherence. They also emphasize the potential for lower doses of ciclesonide, potentially minimizing systemic side effects.

Ciclesonide: A Potential Solution for Childhood Asthma

This research highlights the potential of ciclesonide, a new inhaled corticosteroid, as a promising treatment option for children with chronic asthma. The study emphasizes ciclesonide's advantages, including targeted delivery, once-daily dosing, and potentially lower doses, which may improve adherence and reduce systemic side effects. This research provides valuable insight for clinicians seeking to optimize asthma management in children, minimizing the impact on their growth and well-being.

Managing Asthma in Children: Optimizing Treatment and Safety

For parents of children with asthma, understanding treatment options and potential side effects is crucial. This study explores the potential of ciclesonide, a new inhaled corticosteroid, as a safe and effective option for managing childhood asthma. It's important to discuss with your child's doctor the benefits and risks of different asthma treatments, ensuring that the chosen approach effectively controls symptoms while minimizing potential side effects.

Dr. Camel's Conclusion

Like a camel navigating a desert with changing winds, parents of children with asthma face the challenge of managing a chronic condition. This study, like a refreshing oasis, provides hope for a new treatment option in ciclesonide, an inhaled corticosteroid with potential advantages for childhood asthma. It's a reminder that research and innovation continue to offer new possibilities for managing complex medical conditions, bringing hope for a brighter future for children with asthma.

Date :
  1. Date Completed 2013-03-28
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

23450613

DOI: Digital Object Identifier

10.1002/14651858.CD010352

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.